Merck KGaA (MKKGY) Stock Chart & Stock Price History $26.33 +0.45 (+1.74%) As of 08/22/2025 03:55 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock Merck KGaA Stock Price Performance The Merck KGaA (MKKGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 31.40%, with a year-to-date return of -8.03%. In the past month, the stock has decreased 1.79%, reflecting recent market activity. As of the latest close, Merck KGaA traded at $26.33 with a market cap of $17.01 billion and volume of 94,453 shares. Five years ago, the stock traded at $26.83, representing a 1.86% decrease over that period. At the time, it had a market cap of $0.00 and a volume of 32,474 shares. Receive MKKGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.62%1 Month Performance-1.79%3 Month Performance+1.31%Year-To-Date Performance-8.03%1 Year Performance-31.40%5 Year Performance-1.86% MKKGY Stock Chart for Sunday, August, 24, 2025 MKKGY Chart by TradingView Merck KGaA Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$25.84$26.33+1.88%$26.40$26.0294,453 shs$17.01 billion08/21/2025$26.07$25.84-0.87%$26.22$25.7082,334 shs$16.70 billion08/20/2025$25.91$26.07+0.62%$26.23$26.0355,157 shs$16.85 billion08/19/2025$25.88$25.91+0.12%$26.06$25.78240,868 shs$16.74 billion08/18/2025$26.43$25.88-2.08%$25.94$25.58245,498 shs$16.72 billion08/15/2025$25.82$26.43+2.36%$26.46$26.1582,302 shs$17.08 billion08/14/2025$26.06$25.82-0.92%$26.03$25.7675,630 shs$16.69 billion08/13/2025$26.11$26.06-0.20%$26.28$25.8371,440 shs$16.84 billion08/12/2025$25.19$26.11+3.66%$26.20$25.49130,784 shs$16.87 billion08/11/2025$25.39$25.19-0.79%$25.39$24.91489,913 shs$16.28 billion Get the Latest News and Ratings for MKKGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$24.53$25.39+3.51%$25.49$24.99569,158 shs$16.41 billion08/07/2025$24.69$24.53-0.64%$24.65$24.36208,815 shs$15.85 billion08/06/2025$25.07$24.69-1.53%$24.98$24.55124,052 shs$15.95 billion08/05/2025$25.21$25.07-0.56%$25.14$24.86161,291 shs$16.20 billion08/04/2025$24.96$25.21+1.00%$25.26$24.87160,023 shs$16.29 billion08/01/2025$25.16$24.96-0.79%$25.07$24.79211,878 shs$16.13 billion07/31/2025$25.49$25.16-1.30%$25.43$25.01257,074 shs$16.26 billion07/30/2025$26.16$25.49-2.56%$25.84$25.37129,402 shs$16.47 billion07/29/2025$26.20$26.16-0.15%$26.34$26.09100,512 shs$16.90 billion07/28/2025$26.67$26.20-1.76%$26.51$26.2059,419 shs$16.93 billion07/25/2025$26.81$26.67-0.52%$26.67$26.1273,687 shs$17.23 billion07/24/2025$26.79$26.81+0.07%$26.92$26.67107,334 shs$17.32 billion07/23/2025$25.77$26.79+3.96%$26.82$26.0579,438 shs$17.31 billion Related Companies Zoetis Stock Chart Takeda Pharmaceutical Stock Chart Daiichi Sankyo Stock Chart BeOne Medicines Stock Chart Sandoz Group Stock Chart Summit Therapeutics Stock Chart Shionogi & Co., Ltd. Unsponsored ADR Stock Chart United Therapeutics Stock Chart Neurocrine Biosciences Stock Chart Orion OYJ Stock Chart Receive MKKGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MKKGY) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access